MNPR Monopar Therapeutics Inc. - Common Stock
NASDAQ · Biotechnology · Lihat di SEC EDGAR ↗ tutup Okt 2, 2026 10-K/10-Q Agu 12, 2026
$77,97
· % dari rentang 52 mgg
· di atas terendah
· ke tinggi
$50,07rendah 52m
$124,82tinggi 52m
Kapitalisasi Pasar (MRQ)
$523M
Pendapatan
$0
lencana Anda
Rentang 52M
$50–$125
Peringkat Analis
BUY
Target Harga
$130
P/E
·
ROE
·
Margin Laba Bersih
·
Strip lencana Anda kosong — sematkan metrik di mana saja di halaman ini.
MNPR Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$77.97
Kapitalisasi Pasar (MRQ)
$523M
Pendapatan
$0
Rentang 52M
$50–$125
MNPR Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
rentang
batang
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Pemecahan saham
| Tanggal ex-dividen | Pemecahan | Tipe |
|---|---|---|
| 13 Agu 2024 | 1-for-5 | Terbalik |
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan$02016-12-31 → 2025-12-31
Margin bersih·2020-12-31 → 2022-12-31
Valuasi & Rasio
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
| Metrik | Tren 5 Tahun | MNPR | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| P/B (MRQ) | 4.0rata-rata 5T ≈8.2 | ≈8.2 | 2.4 | Terlalu mahal | |
| Price / Tangible Book (Harga / Nilai Buku Berwujud) | 3.2rata-rata 5T ≈7.2 | ≈7.2 | · | · |
Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
Belum ada data untuk grup rasio ini
Data fundamental belum cukup untuk menghitung grup rasio ini.
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
| Metrik | Tren 5 Tahun | MNPR | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Rasio Lancar (MRQ) | 33.6 | · | 11.6 | Likuiditas kuat |
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Belum ada data untuk grup rasio ini
Data fundamental belum cukup untuk menghitung grup rasio ini.
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
| Metrik | Tren 5 Tahun | MNPR | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Revenue / Employee (Pendapatan Tahunan ÷ karyawan (jumlah karyawan, yfinance). Turunan — bukan konsep SEC-XBRL yang tersimpan.) | ≈$0.00 | · | · | · |
nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
-65.4%
Laporan Berikutnya
Nov 11, 2026
| Periode | Laporan | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|---|
| 30 Juni 2026 | Agu 10, 2026 | $-0.62 | $-0.63 | 2.1% |
| 31 Maret 2026 | Mei 14, 2026 | $-0.46 | $-0.85 | 46.0% |
| 31 Des. 2025 | $-0.64 | $-0.50 | -27.3% | |
| 30 Sep. 2025 | $-0.48 | $-0.44 | -9.4% | |
| 30 Juni 2025 | $-0.35 | $-0.48 | 27.3% | |
| 31 Maret 2025 | $-0.38 | $-0.69 | 45.2% | |
| 31 Des. 2024 | $-2.75 | $-0.43 | -541.9% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | · | · | · | $0 | $0 | $0 | |
| R&D Expense | $10M | $13M | $6M | $8M | $6M | $4M | $2M | $2M | $935.3K | |
| SG&A Expense | $7M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $1M | |
| Operating Expenses | $17M | $16M | $9M | $11M | $9M | $7M | $4M | $3M | $17M | |
| Operating Income | $-17M | $-16M | $-9M | $-11M | $-9M | $-7M | $-4M | $-3M | $-17M | |
| Interest Income | $3M | $404.0K | $429.0K | · | · | · | · | · | · | |
| Pretax Income | $-14M | $-16M | $-8M | · | · | · | · | $-3M | $-17M | |
| Income Tax | $800 | $800 | $800 | $800 | $0 | $18.4K | $0 | $-70.8K | $-3.6K | |
| Net Income | $-14M | $-16M | $-8M | $-11M | $-9M | $-6M | $-4M | $-3M | $-17M | |
| EPS (Basic) | $-1.85 | $-4.11 | $-3.04 | $-0.83 | · | · | · | · | · | |
| Shares (Basic) | 7,411,121 | 3,790,202 | 2,764,790 | 12,718,166 | 12,471,217 | · | · | · | · | |
| EBITDA | · | $-16M | $-9M | $-11M | $-9M | $-7M | $-4M | $-3M | · |
Neraca
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $62M | $46M | $7M | $8M | $20M | $17M | $13M | $7M | $9M | |
| Other Current Assets | $63.7K | $78.9K | $66.4K | $46.0K | $217.7K | $62.7K | $15.7K | · | · | |
| Current Assets | $140M | $60M | $7M | $13M | $21M | $17M | $13M | $7M | $9M | |
| Other Non-current Assets | · | · | · | · | $0 | $68.9K | $122.4K | $65.7K | · | |
| Total Assets | $141M | $60M | $7M | $13M | $21M | $17M | $13M | $7M | $10M | |
| Accounts Payable | $3M | $2M | $2M | $3M | $2M | $1M | $724.2K | $399.6K | $311.9K | |
| Current Liabilities | $3M | $5M | $2M | $3M | $2M | $1M | $724.2K | $399.6K | $311.9K | |
| Capital Leases | $154.9K | $0 | $0 | $8.4K | $0 | · | · | · | · | |
| Total Liabilities | $3M | $5M | $2M | $3M | $2M | $1M | $724.2K | $399.6K | $311.9K | |
| Common Stock | $6.7K | $6.1K | $3.0K | $12.9K | $12.6K | $11.5K | $10.6K | $9.3K | $9.3K | |
| Paid-in Capital | · | · | · | $62M | $60M | $48M | $39M | $29M | $28M | |
| Retained Earnings | $-90M | $-76M | $-60M | $-52M | $-41M | $-32M | $-26M | $-22M | $-18M | |
| AOCI | $131.4K | $36.0K | $-14.1K | $8.9K | $-3.2K | $-7.9K | $-11.0K | $-2.4K | $0 | |
| Stockholders' Equity | $138M | $55M | $6M | $10M | $19M | $16M | $13M | $7M | $10M | |
| Liabilities + Equity | $141M | $60M | $7M | $13M | $21M | $17M | $13M | $7M | $10M | |
| Shares Outstanding | 6,692,140 | 6,102,560 | 2,980,900 | 12,946,573 | 12,598,125 | 11,453,465 | 10,587,632 | 9,291,421 | 9,291,421 |
Arus Kas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $5M | $1M | $2M | $2M | · | · | · | · | · | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $-71.6K | $0 | |
| Operating Cash Flow | $-12M | $-6M | $-8M | $-7M | $-7M | $-5M | $-3M | $-3M | $-3M | |
| Investing Cash Flow | $-63M | $-14M | $5M | $-5M | $0 | · | · | · | · | |
| Stock Issued | $0 | $4M | $2M | $109.3K | · | $8M | $0 | $0 | $5M | |
| Stock Repurchased | $35M | $0 | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $4M | $2M | · | · | $8M | · | $0 | · | |
| Financing Cash Flow | $92M | $59M | $2M | $32.9K | $11M | $8M | $9M | $-206.3K | $10M | |
| Net Change in Cash | $16M | $39M | $-920.1K | $-12M | $4M | $4M | $6M | $-3M | $7M | |
| Taxes Paid | · | · | · | · | $0 | $-11.1K | $53 | · | · |
Profitabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | -49611.0% | -37992.2% | -7947.2% | · | · | · | |
| Net Margin | · | · | · | -49511.0% | -37892.2% | -7697.7% | · | · | · | |
| EBITDA Margin | · | · | · | -49611.0% | -37992.2% | -7947.2% | · | · | · | |
| ROA | · | -46.1% | -81.7% | -62.3% | -48.7% | -41.7% | -40.9% | -37.4% | · | |
| ROE | · | -52.0% | -137.8% | -93.1% | -45.3% | -38.0% | -49.0% | -44.5% | · | |
| ROIC | · | -29.4% | · | · | · | · | · | -48.1% | · |
Likuiditas & Solvabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | · | 4.2 | 4.2 | · | 14.3 | 18.3 | 18.3 | · | |
| Quick Ratio | · | · | 4.1 | 2.6 | · | 14.2 | 18.2 | 17.3 | · |
Efisiensi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · |
Per Saham
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $9.02 | $0.37 | $0.78 | $1.50 | $1.37 | $1.19 | $0.74 | · | |
| Cash / Share | · | $7.51 | $0.49 | $0.63 | $1.61 | $1.46 | $1.25 | $0.74 | · |
Valuasi (TTM)
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income TTM | $-14M | $-16M | $-8M | $-11M | $-9M | $-6M | $-4M | $-3M | $-17M | |
| Market Cap | · | $134M | $25M | $153M | $202M | $350M | $879M | · | · | |
| P/B | · | 2.4 | 4.5 | 15.2 | 10.7 | 22.3 | 69.6 | · | · | |
| P / Tangible Book | 3.2 | 2.4 | 4.5 | 15.2 | 10.7 | 22.3 | · | · | · | |
| P / Cash Flow | · | -21.0 | -3.2 | -21.2 | 27.6 | -75.2 | -291.2 | · | · |
Laporan Laba Rugi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| R&D Expense | $5M | $3M | $4M | $3M | $2M | $2M | $10M | $984.3K | $1M | $966.1K | $1M | $1M | $2M | $2M | $2M | $2M | |
| SG&A Expense | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $590.6K | $657.8K | $757.3K | $876.4K | $749.5K | $733.5K | $871.7K | $806.0K | $675.1K | |
| Operating Expenses | $7M | $5M | $6M | $4M | $3M | $3M | $11M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $2M | |
| Operating Income | $-7M | $-5M | $-6M | $-4M | $-3M | $-3M | $-11M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-3M | $-2M | |
| Interest Income | $1M | $1M | $954.4K | $655.5K | $780.8K | $596.8K | $149.0K | $99.3K | $73.5K | $82.2K | $98.1K | $112.3K | · | · | · | · | |
| Net Income | $-5M | $-4M | $-5M | $-3M | $-2M | $-3M | $-11M | $-1M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-2M | |
| EPS (Basic) | $-0.62 | $-0.46 | $-0.64 | $-0.48 | $-0.35 | $-0.38 | $-2.74 | $-0.37 | $-0.49 | $-0.51 | $-2.00 | $-0.69 | $-0.16 | $-0.19 | $-0.23 | $-0.19 | |
| Shares (Basic) | 8,542,450 | 8,535,443 | · | 7,123,849 | 6,998,082 | 6,987,381 | · | 3,520,398 | 3,502,927 | 3,195,963 | · | 2,823,680 | 13,420,029 | 13,105,831 | · | 12,754,685 | |
| EBITDA | $-7M | $-5M | · | $-4M | $-3M | $-3M | · | $-2M | $-2M | $-2M | · | $-2M | $-2M | $-3M | · | $-2M |
Neraca
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $53M | $53M | $62M | $128M | $40M | $40M | $46M | $6M | $6M | $8M | $7M | $6M | $7M | $6M | $8M | $14M | |
| Other Current Assets | $464.7K | $250.9K | $63.7K | $414.8K | $497.3K | $523.6K | $78.9K | $49.6K | $61.0K | $119.0K | $66.4K | $73.2K | $109.9K | $106.8K | $46.0K | $55.7K | |
| Current Assets | $135M | $138M | $140M | $144M | $54M | $55M | $60M | $6M | $7M | $9M | $7M | $9M | $10M | $12M | $13M | $14M | |
| Total Assets | $135M | $138M | $141M | $144M | $54M | $55M | $60M | $6M | $7M | $9M | $7M | $9M | $10M | $12M | $13M | $14M | |
| Accounts Payable | $4M | $2M | $3M | $3M | $2M | $1M | $2M | $1M | $1M | $1M | $2M | $2M | $3M | $3M | $3M | $2M | |
| Current Liabilities | $4M | $2M | $3M | $3M | $2M | · | $5M | · | · | · | · | $2M | $3M | $3M | $3M | $2M | |
| Capital Leases | $107.8K | $131.6K | $154.9K | $70.9K | $80.4K | · | $0 | · | · | · | · | $0 | $0 | $0 | $8.4K | $20.9K | |
| Total Liabilities | $4M | $3M | $3M | $3M | $2M | $1M | $5M | $1M | $1M | $1M | $2M | $2M | $3M | $3M | $3M | $2M | |
| Common Stock | $6.7K | $6.7K | $6.7K | $6.7K | $6.1K | $6.1K | $6.1K | $3.5K | $17.6K | $17.5K | $3.0K | $14.2K | $13.9K | $13.2K | $12.9K | $12.9K | |
| Paid-in Capital | · | · | · | · | · | · | · | · | · | · | · | · | · | $63M | · | $61M | |
| Retained Earnings | $-99M | $-93M | $-90M | $-84M | $-81M | $-78M | $-76M | $-65M | $-64M | $-62M | $-60M | $-58M | $-56M | $-54M | $-52M | $-49M | |
| AOCI | $91.3K | $98.5K | $131.4K | $11.7K | $77.6K | $-21.8K | $36.0K | $-11.0K | $8.3K | $4.2K | $-14.1K | $3.9K | $7.2K | $31.8K | $8.9K | $43.0K | |
| Stockholders' Equity | $131M | $135M | $138M | $142M | $52M | $54M | $55M | $5M | $6M | $7M | $6M | $7M | $8M | $9M | $10M | $13M | |
| Liabilities + Equity | $135M | $138M | $141M | $144M | $54M | $55M | $60M | $6M | $7M | $9M | $7M | $9M | $10M | $12M | $13M | $14M | |
| Shares Outstanding | 6,712,172 | 6,699,062 | 6,692,140 | 6,662,930 | 6,127,457 | 6,115,214 | 6,102,560 | 3,525,079 | 17,601,827 | 17,484,175 | 2,980,900 | 14,198,438 | 13,898,081 | 13,222,056 | 12,946,573 | 12,855,735 |
Arus Kas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $1M | $2M | $1M | $1M | $1M | $1M | $278.6K | $199.1K | $334.4K | $328.7K | $474.2K | $474.1K | $473.3K | $476.2K | $393.4K | $390.7K | |
| Operating Cash Flow | $-3M | $-3M | $-3M | $-2M | $-1M | $-6M | $-2M | $-1M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-1M | $-2M | |
| Investing Cash Flow | $4M | $-6M | $-62M | $-2M | $1M | $-325.8K | $-14M | $985.7K | $-2.4K | $-983.3K | $3M | $-13.1K | $3M | $-983.4K | $-5M | $0 | |
| Stock Issued | · | · | $0 | $0 | $0 | $0 | $1M | $0 | $-1 | $3M | $339.9K | $254.9K | $657.8K | $821.6K | $109.3K | $0 | |
| Stock Repurchased | · | · | $0 | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | · | · | · | · | $0 | · | · | · | $3M | · | · | · | · | · | · | |
| Financing Cash Flow | $-647.4K | $-200.2K | $-384.7K | $92M | $-316.8K | $-115.7K | $56M | $-16.5K | $-9.9K | $3M | $334.5K | $246.7K | $641.2K | $804.8K | $138.7K | $-23.7K | |
| Net Change in Cash | $213.5K | $-9M | $-66M | $88M | $-209.5K | $-6M | $40M | $-99.8K | $-2M | $541.5K | $2M | $-2M | $1M | $-2M | $-6M | $-2M |
Profitabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | -2434.6% | -2097.5% | · | -1840.4% | -1815.8% | -2790.5% | · | -31272.3% | |
| Net Margin | · | · | · | · | · | · | · | · | -2334.6% | -1997.5% | · | -1740.4% | -1715.8% | -2690.5% | · | -31172.3% | |
| EBITDA Margin | · | · | · | · | · | · | · | · | -2434.6% | -2097.5% | · | -1840.4% | -1815.8% | -2790.5% | · | -31272.3% | |
| ROA | -5.6% | -4.0% | · | -4.6% | -8.0% | -8.2% | · | -17.8% | -19.6% | -15.8% | · | -17.0% | -16.2% | -16.3% | · | -13.0% | |
| ROE | -5.8% | -4.1% | · | -4.7% | -8.4% | -8.6% | · | -22.6% | -24.6% | -20.0% | · | -20.4% | -19.7% | -18.8% | · | -14.2% |
Likuiditas & Solvabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 33.6 | 56.0 | · | 56.1 | 33.9 | · | · | · | · | · | · | 4.3 | 4.1 | 4.1 | · | 7.5 | |
| Quick Ratio | 13.1 | 21.4 | · | 49.7 | 24.9 | · | · | · | · | · | · | 2.8 | 2.9 | 2.0 | · | 7.5 |
Efisiensi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.0 | · | · | · | · | · | · | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 |
Per Saham
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $19.50 | $20.21 | · | $21.25 | $8.52 | $8.76 | · | $1.40 | $0.35 | $0.43 | · | $0.47 | $0.56 | $0.68 | · | $0.97 | |
| Cash / Share | $7.86 | $7.84 | · | $19.16 | $6.45 | $6.49 | · | $1.71 | $0.35 | $0.45 | · | $0.39 | $0.52 | $0.43 | · | $1.11 |
Valuasi (TTM)
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | |
| Net Income TTM | $-18M | $-15M | · | $-19M | $-17M | $-17M | · | $-6M | $-7M | $-8M | · | $-9M | $-10M | $-10M | · | $-10M | |
| Market Cap | $621M | $367M | · | $544M | $219M | $223M | · | $24M | $64M | $60M | · | $44M | $59M | $92M | · | $98M | |
| P/B | 4.7 | 2.7 | · | 3.8 | 4.2 | 4.2 | · | 4.8 | 10.5 | 8.0 | · | 6.7 | 7.6 | 10.3 | · | 7.8 | |
| P / Tangible Book | 4.7 | 2.7 | · | 3.8 | 4.2 | 4.2 | · | 4.8 | 10.5 | 8.0 | · | 6.7 | 7.6 | 10.3 | · | 7.8 | |
| P / Cash Flow | · | -105.7 | · | · | · | -39.3 | · | · | · | -36.0 | · | · | · | -40.5 | · | · |
Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Pendapatan | $0 | $0 | $0 | · | · |
| Margin Operasi % | · | · | · | -49611.0% | -37992.2% |
| Laba Bersih | $-14M | $-16M | $-8M | $-11M | $-9M |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Rasio Lancar | · | · | 4.2 | 4.2 | · |
| Rasio Cepat | · | · | 4.1 | 2.6 | · |
Tidak ada data untuk laporan ini
Data fundamental belum cukup untuk membuat laporan ini.
Pemilik institusional (13F) 98 pengaju · $544.8M total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Pemegang
98
Nilai yang dipegang
$544.8M
Posisi baru
29
Posisi yang keluar
14
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 29 (+10 vs Kuartal sebelumnya) | 14 (+5 vs Kuartal sebelumnya) | 31 (-2 vs Kuartal sebelumnya) | 24 (+6 vs Kuartal sebelumnya) | -1.3M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | $72.062.327 | 1.317.410 | 13,23% | Saham |
| RA CAPITAL MANAGEMENT, L.P. | $61.776.696 | 667.207 | 11,34% | Saham |
| BlackRock, Inc. | $32.297.151 | 348.819 | 5,93% | Saham |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $29.975.550 | 323.745 | 5,50% | Saham |
| Saturn V Capital Management LP | $28.885.858 | 311.976 | 5,30% | Saham |
| Siren, L.L.C. | $25.010.226 | 270.118 | 4,59% | Saham |
| ADAR1 Capital Management, LLC | $20.147.121 | 217.595 | 3,70% | Saham |
| Polar Capital Holdings Plc | $19.857.685 | 214.469 | 3,65% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $19.417.141 | 209.711 | 3,56% | Saham |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $19.369.365 | 209.195 | 3,56% | Saham |
| VANGUARD GROUP INC | $19.186.185 | 293.816 | 3,52% | Saham |
| TCG Crossover Management, LLC | $18.826.047 | 203.327 | 3,46% | Saham |
| WELLINGTON MANAGEMENT GROUP LLP | $14.669.682 | 158.437 | 2,69% | Saham |
| ORBIMED ADVISORS LLC | $14.575.796 | 157.423 | 2,68% | Saham |
| Candriam S.C.A. | $13.258.989 | 143.339 | 2,43% | Saham |
| Balyasny Asset Management L.P. | $12.457.336 | 134.543 | 2,29% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $10.426.384 | 112.578 | 1,91% | Saham |
| Alyeska Investment Group, L.P. | $9.259.000 | 100.000 | 1,70% | Saham |
| STATE STREET CORP | $8.569.297 | 92.551 | 1,57% | Saham |
| Vivo Capital, LLC | $8.379.395 | 90.500 | 1,54% | Saham |
| Driehaus Capital Management LLC | $7.781.264 | 84.040 | 1,43% | Saham |
| Bank of New York Mellon Corp | $7.124.057 | 76.942 | 1,31% | Saham |
| Vestal Point Capital, LP | $7.011.563 | 75.727 | 1,29% | Saham |
| Longaeva Partners L.P. | $5.169.670 | 55.834 | 0,95% | Saham |
| NEUBERGER BERMAN GROUP LLC | $5.110.413 | 55.194 | 0,94% | Saham |
| MILLENNIUM MANAGEMENT LLC | $4.658.295 | 50.311 | 0,86% | Saham |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $4.519.873 | 48.816 | 0,83% | Saham |
| Ikarian Capital, LLC | $4.431.450 | 47.861 | 0,81% | Saham |
| CITADEL ADVISORS LLC | $3.426.200 | 37.004 | 0,63% | Saham |
| NORTHERN TRUST CORP | $3.207.411 | 34.641 | 0,59% | Saham |
| DEUTSCHE BANK AG\ | $2.871.031 | 31.008 | 0,53% | Saham |
| STEMPOINT CAPITAL LP | $2.789.274 | 30.125 | 0,51% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $2.618.445 | 28.280 | 0,48% | Saham |
| UBS Group AG | $2.523.911 | 27.259 | 0,46% | Saham |
| MORGAN STANLEY | $1.659.121 | 17.919 | 0,30% | Saham |
| AMERIPRISE FINANCIAL INC | $1.648.102 | 17.800 | 0,30% | Saham |
| GOLDMAN SACHS GROUP INC | $1.496.347 | 16.161 | 0,27% | Saham |
| Russell Investments Group, Ltd. | $1.374.961 | 14.850 | 0,25% | Saham |
| BOOTHBAY FUND MANAGEMENT, LLC | $1.360.055 | 14.689 | 0,25% | Saham |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1.291.908 | 13.953 | 0,24% | Saham |
| Ishara Investments LP | $1.138.857 | 12.300 | 0,21% | Saham |
| TWO SIGMA INVESTMENTS, LP | $1.134.413 | 12.252 | 0,21% | Saham |
| Trexquant Investment LP | $1.111.450 | 12.004 | 0,20% | Saham |
| Creative Planning | $719.239 | 7.768 | 0,13% | Saham |
| XTX Topco Ltd | $605.168 | 6.536 | 0,11% | Saham |
| Nuveen, LLC | $553.688 | 5.980 | 0,10% | Saham |
| BARCLAYS PLC | $540.077 | 5.833 | 0,10% | Saham |
| RHUMBLINE ADVISERS | $521.271 | 5.630 | 0,10% | Saham |
| GERBER, LLC | $518.597 | 5.601 | 0,10% | Saham |
| Virtus Investment Advisers, LLC | $506.838 | 5.474 | 0,09% | Saham |
Aktivis & pemilik 5%+ 3 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| Tactic Pharma LLC, Robinson Chandler, Brown Michael J ×4 pengajuan | 30 Jan. 2026 | 4,50% | Amandemen | · | SEC |
| Monopar Therapeutics, Hendricks Diane, Leo Karl, Pharma Investments LLC | 7 Feb. 2025 | 13,40% | Amandemen | · | SEC |
| GEM PHARMACEUTICALS LLC, DIANE HENDRICKS, KARL LEO, ARTHUR KLAUSNER, PHARMA INVESTMENTS LLC | 23 Des. 2019 | · | Pengajuan awal | Investasi pasif | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Orang dalam perusahaan 18 orang dalam · 7 pejabat · 9 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Robinson Chandler | Chief Executive Officer | 30 Sep. 2026 M | 104.724 | 0 | 4 | $-2.556.851 |
| Quan Anh Vu | Chief Financial Officer | 30 Sep. 2026 M | 2.655 | 1 | 0 | $104.925 |
| Karthik Radhakrishnan | Chief Financial Officer | 28 Okt. 2024 P | 1.550 | 0 | 0 | $0 |
| Andrew Cittadine | Chief Operating Officer | 30 Sep. 2026 M | 58.054 | 0 | 0 | $0 |
| Susan Rodriguez | CCSO | 2 Maret 2026 A | · | 0 | 0 | $0 |
| Mazar Andrew Paul | Chief Scientific Officer | 31 Maret 2022 M | 22.125 | 0 | 0 | $0 |
| Jose Octavio Pinto Costa Filho | Chief Medical Officer | 12 Juli 2021 A | · | 0 | 0 | $0 |
| Kim R Tsuchimoto | Direktur | 26 Agu 2026 M | 0 | 0 | 12 | $-911.134 |
| Raymond Anderson | Direktur | 25 Agu 2026 M | 5.373 | 0 | 6 | $-703.024 |
| Nicole Sweeny | Direktur | 26 Juni 2026 A | · | 0 | 0 | $0 |
| Arthur J Klausner | Direktur | 18 Des. 2025 S | 8.762 | 0 | 2 | $-343.889 |
| Lavina Talukdar | Direktur | 2 Des. 2025 A | · | 0 | 0 | $0 |
| Christopher M Starr | Direktur | 2 Des. 2025 A | 5.173 | 0 | 0 | $0 |
| Brown Michael J | Direktur | 31 Des. 2023 M | 235.863 | 0 | 0 | $0 |
| Hendricks Diane | Pemilik 10% | 16 Des. 2025 J | 567.580 | 0 | 0 | $0 |
| TacticGem LLC | Pemilik 10% | 9 Des. 2024 J | 0 | 0 | 0 | $0 |
| Leo Karl | Pemilik 10% | 18 Des. 2019 P | 314 | 0 | 0 | $0 |
| Patrice Rioux | · | 26 Agu 2026 M | 5.065 | 0 | 1 | $-111 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Kepemilikan ETF Dimiliki oleh 15 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 1,21% | 5.200 NS | 31 Juli 2026 | N-PORT |
| IWC · iShares Trust | 0,12% | 15.317 SH | 11 Sep. 2026 | Harian |
| VFMO · VANGUARD WELLINGTON FUND | 0,08% | 18.350 SH | 19 Agu 2026 | Harian |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 2.949 SH | 19 Agu 2026 | Harian |
| IWM · iShares Trust | 0,02% | 116.579 SH | 11 Sep. 2026 | Harian |
| RSSL · Global X Funds | 0,02% | 2.170 NS | 31 Juli 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 25.913 SH | 19 Agu 2026 | Harian |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 1.184 SH | 19 Agu 2026 | Harian |
| IWO · iShares Trust | 0,01% | 10.465 SH | 11 Sep. 2026 | Harian |
| ITOT · iShares Trust | 0,00% | 9.936 SH | 11 Sep. 2026 | Harian |
| IWV · iShares Trust | 0,00% | 1.853 SH | 9 Sep. 2026 | Harian |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 45.173 SH | 19 Agu 2026 | Harian |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 159.786 SH | 19 Agu 2026 | Harian |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 420 SH | 19 Agu 2026 | Harian |
| IWN · iShares Trust | · | 31.559 SH | 11 Sep. 2026 | Harian |
MNPR Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
peringkat · 19 analis
BELI
Target median
$130.00
+66,7%
4 21,1%
Beli Kuat
13 68,4%
Beli
2 10,5%
Tahan
0 0,0%
Jual
0 0,0%
Jual Kuat
Target Harga 12 Bulan
12 analis · 2026-10-04Target rata-rata $129.92 +66,6%
← Di bawah semua target
Harga saat ini $77.97
Rendah$119.00
Rata-rata$129.92
Tinggi$145.00
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| MNPR | · | · | · | · | · | · |
| CBIO | $327M | -24.2 | -86.7% | -1419.6% | -90.0% | · |
| ALT | $400M | -3.6 | 105.0% | -214861.0% | -45.6% | · |
| ZURA | · | · | · | · | · | · |
| ALLO | $314M | -1.6 | -76.8% | · | -59.9% | · |
| PROK | · | · | 1075.0% | -7725.2% | 6.9% | · |
| CAPR | $1.66B | -12.8 | -11.6% | · | -51.1% | · |
| NGNE | $319M | -4.9 | · | · | -33.6% | · |
| PBYI | $300M | 9.8 | -0.91% | 13.6% | 26.5% | · |
| RGNX | $733M | -3.8 | 104.5% | -113.8% | -122.5% | · |
| OVID | $212M | -4.0 | 1181.3% | -240.1% | -18.7% | · |
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Sumber: SEC 10-Q diajukan Agu 12, 2026